1Department of Molecular Sciences, AstraZeneca R&D, Södertälje, S-151 87 Södertälje, Sweden. Hugh.Salter@astrazeneca.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Genomics offers great potential for improving molecular safety assessments by enhancing mechanistic understanding and compound prediction. Standardization of biological and technical issues is crucial for operationalizing emerging toxicogenomics databases.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: